Literature DB >> 24012028

Effect of fragility on quality of life in patients with heart failure.

Paloma Gastelurrutia1, Josep Lupón, Salvador Altimir, Marta de Antonio, Beatriz González, Roser Cabanes, Lucía Cano, Agustín Urrutia, Mar Domingo, Elisabet Zamora, Crisanto Díez, Ramon Coll, Antoni Bayes-Genis.   

Abstract

Heart failure (HF) is a chronic disease that frequently causes quality of life (QoL) impairment. We aimed to evaluate whether fragility affects QoL perception in outpatients with HF across age strata. The Minnesota Living with Heart Failure Questionnaire (MLWHFQ) was used to assess QoL, and fragility was defined according to basic standardized geriatric scales. Predefined criteria for such scales were scores of Barthel index <90, Older Americans' Resources and Services scale <10 in women and <6 in men, and Pfeiffer test >3 (±1 depending on educational grade) and ≥1 positive depression response on the abbreviated Geriatric Depression Scale. We evaluated 1,405 consecutive outpatients with HF (27.8% women, median age 69 years [twenty-fifth to seventy-fifth percentiles: 59 to 76 years]). Fragility, defined as at least 1 abnormal evaluation, was detected in 621 patients (44.2%). A positive depression response on the abbreviated Geriatric Depression Scale was the most prevalent (31.2%) component of fragility. We found a strong correlation between MLWHFQ score and the presence of fragility and all fragility components (all p <0.001). These associations prevailed in both younger (<75 years) and older patients (≥75 years; all p values <0.001 except for Pfeiffer test in younger patients [p = 0.007]). In multivariate regression analysis, QoL remained significantly associated with fragility after adjustment for age, gender, etiology of HF, left ventricular ejection fraction, New York Heart Association functional class, co-morbidities, and HF treatment, in both younger and older patients (p <0.001). In conclusion, MLWHFQ, a specific HF QoL questionnaire, is significantly influenced by fragility regardless of age.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24012028     DOI: 10.1016/j.amjcard.2013.08.002

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Contribution of the long-term care insurance certificate for predicting 1-year all-cause readmission compared with validated risk scores in elderly patients with heart failure.

Authors:  Kayo Takahashi; Makoto Saito; Shinji Inaba; Toru Morofuji; Hiroe Aisu; Takumi Sumimoto; Akiyoshi Ogimoto; Shuntaro Ikeda; Jitsuo Higaki
Journal:  Open Heart       Date:  2016-11-30

2.  Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Xiaobo Yang; Josep Lupón; Maria T Vidán; Caleb Ferguson; Paloma Gastelurrutia; Phillip J Newton; Peter S Macdonald; Héctor Bueno; Antoni Bayés-Genís; Jean Woo; Erik Fung
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

3.  Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study.

Authors:  Laurence Halimi; Carey M Suehs; Gregory Marin; Clement Boissin; Anne-Sophie Gamez; Isabelle Vachier; Nicolas Molinari; Arnaud Bourdin
Journal:  ERJ Open Res       Date:  2021-08-23

4.  Randomized Controlled Trial Comparing a Multidisciplinary Intervention by a Geriatrician and a Cardiologist to Usual Care after a Heart Failure Hospitalization in Older Patients: The SENECOR Study.

Authors:  Marta Herrero-Torrus; Neus Badosa; Cristina Roqueta; Sonia Ruiz-Bustillo; Eduard Solé-González; Laia C Belarte-Tornero; Sandra Valdivielso-Moré; Olga Vázquez; Núria Farré
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

5.  Heart Failure and Frailty in the Community-Living Elderly Population: What the UFO Study Will Tell Us.

Authors:  Erik Fung; Elsie Hui; Xiaobo Yang; Leong T Lui; King F Cheng; Qi Li; Yiting Fan; Daljit S Sahota; Bosco H M Ma; Jenny S W Lee; Alex P W Lee; Jean Woo
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

6.  Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.

Authors:  Paloma Gastelurrutia; Josep Lupón; Pedro Moliner; Xiaobo Yang; German Cediel; Marta de Antonio; Mar Domingo; Salvador Altimir; Beatriz González; Margarita Rodríguez; Carmen Rivas; Violeta Díaz; Erik Fung; Elisabet Zamora; Javier Santesmases; Julio Núñez; Jean Woo; Antoni Bayes-Genis
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-04-19

7.  Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study.

Authors:  Elena Revuelta-López; Julio Núñez; Paloma Gastelurrutia; Germán Cediel; James L Januzzi; Nasrien E Ibrahim; Michele Emdin; Roland VanKimmenade; Domingo Pascual-Figal; Eduardo Núñez; Frank Gommans; Josep Lupón; Antoni Bayés-Genís
Journal:  ESC Heart Fail       Date:  2020-02-11

Review 8.  Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review.

Authors:  Josep Comín-Colet; Teresa Martín Lorenzo; Almudena González-Domínguez; Juan Oliva; Silvia Jiménez Merino
Journal:  Health Qual Life Outcomes       Date:  2020-10-07       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.